Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

May 1, 2011

Primary Completion Date

September 25, 2012

Study Completion Date

September 25, 2012

Conditions
Dry Eye Syndromes
Interventions
DRUG

carboxymethylcellulose sodium based New Eye Drop Formulation 1

1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation 1 in each eye at least twice daily for 90 days.

DRUG

carboxymethylcellulose sodium based New Eye Drop Formulation 2

1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation 2 in each eye at least twice daily for 90 days.

DRUG

carboxymethylcellulose sodium based Eye Drops

1 to 2 drops of carboxymethylcellulose sodium based Eye Drops (Refresh Tears®) in each eye at least twice daily for 90 days.

Trial Locations (2)

Unknown

Randwick

St. John's

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01294384 - Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease | Biotech Hunter | Biotech Hunter